`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`:
`:
`:
`:
`:
`:
`:
`:
`
`CIVIL ACTION
`
`NO. 22-252
`
`ARBUTUS BIOPHARMA CORPORATION
`and GENEVANT SCIENCES GMBH,
`
`
`
`
`
`
`
`
`
`
`
`
`Plaintiffs,
`
`
`
`
`
`
`
`
`
`
`v.
`
`
`
`
`
`
`
`
`
`
`
`MODERNA, INC. and MODERNATX, INC.,
`
`
`
`
`
`
`
`
`
`ORDER
`
`AND NOW, this 10th day of March, 2023, upon consideration of the supplemental letter briefs
`
`
`
`filed by the parties and the U.S. Government (D.I. 57, 58, 59), the two proposed Amicus Briefs (D.I.
`
`56-2 and D.I. 61-1), and Defendants’ Response in Opposition to the Motions for Leave to File Amicus
`
`Briefs (D.I. 62), it is hereby ORDERED that:
`
`1. The Motions for Leave to File Amicus Briefs (D.I. 56 and 61) are GRANTED;
`
`2. Any requested reconsideration of the November 2, 2022 Memorandum and Order in light of the
`
`Government’s Statement of Interest is DENIED;
`
`3. A Pretrial Scheduling Conference will be held on Thursday, March 16, 2023 at 10:00 a.m. The
`
`conference will be conducted via telephone and held on the record. Counsel are directed
`
`to dial in as follows: (1) Call: 888-684-8852; (2) Enter access code: 2187450#; (3) Press
`
`# to enter as a participant.
`
`
`
`BY THE COURT:
`
`
`
`/s/ Mitchell S. Goldberg
`
`MITCHELL S. GOLDBERG
`
`